Literature DB >> 27481221

Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.

Rui-San Zhang1, Zhen He2, Wei-Dong Jin2, Rui Wang3.   

Abstract

The cannabinoid system plays an important role in memory processes, many studies have indicated that cannabinoid receptor ligands have ability to modulate memory in rodents. A nonapeptide hemopressin (Hp) derived from rat brain, acts as a peptide antagonist or selective inverse peptide agonist of cannabinoid 1 (CB1) receptor. N-terminally extended forms of Hp isolated from mouse brain, (m)RVD-hemopressin(α) (RVD) and (m)VD-hemopressin(α) (VD) also bind CB1 receptor, however, as peptide agonists. Here, we investigated the roles of Hp, RVD, and VD on memory in mice using novel object recognition (NOR) and object location recognition (OLR) tasks. In normal young mice, intracerebroventricular (i.c.v.) infusion of Hp before training not only improved memory formation, but also prolonged memory retention in the tasks, these effects could be inhibited by RVD or VD at the same dose and intraperitoneal (i.p.) injection of a small molecule agonist of CB1 receptor WIN55, 212-2 15min before administration of Hp inhibited the memory-improving effect of Hp. In addition, under the same experimental conditions, i.c.v. RVD or VD displayed memory-impairing effects, which could be prevented by Hp (i.c.v.) or AM251 (i.p.), a small molecule antagonist of CB1 receptor. Infusion of amyloid-β (1-42) (Aβ1-42) 14days before training resulted in impairment of memory in mice which could be used as animal model of Alzheimer's disease (AD). In these mice, RVD or VD (i.c.v.) reversed the memory impairment induced by Aβ1-42, and the effects of RVD and VD could be suppressed by Hp (i.c.v.) or AM251 (2mg/kg, i.p.). Separate administration of Hp had no effect in Aβ1-42-treated mice. The above results suggested that Hp, RVD and VD, as CB1 receptor peptide ligands, may be potential drugs to treatment of the memory deficit-involving disease, just as AD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (m)RVD-hemopressin(α); (m)VD-hemopressin(α); Alzheimer’s disease; Cannabinoid receptor; Hemopressin; Recognition memory

Mesh:

Substances:

Year:  2016        PMID: 27481221     DOI: 10.1016/j.nlm.2016.07.030

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  5 in total

1.  Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage.

Authors:  Vanessa Petrucci; Andrea Chicca; Sandra Glasmacher; Janos Paloczi; Zongxian Cao; Pal Pacher; Jürg Gertsch
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

2.  Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans.

Authors:  Alessandro Emendato; Remo Guerrini; Erika Marzola; Hans Wienk; Rolf Boelens; Serena Leone; Delia Picone
Journal:  Front Mol Biosci       Date:  2018-11-16

Review 3.  Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products.

Authors:  Dongchen An; Steve Peigneur; Louise Antonia Hendrickx; Jan Tytgat
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

4.  Identification of a novel fusion Iduronidase with improved activity in the cardiovascular system.

Authors:  Sarah Kim; Michael J Przybilla; Chester B Whitley; Li Ou; Mahmoud Al-Kofahi; Jeanine R Jarnes
Journal:  Mol Genet Metab Rep       Date:  2022-09-18

5.  Protective Effects of Citicoline and Benfotiamine Each Alone and in Combination on Streptozotocin-induced Memory Impairment in Mice.

Authors:  Maryam Safavi; Ali Hosseini-Sharifabad; Yasaman Seyed-Yousefi; Mohammad Rabbani
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.